COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 658: Articles 6571-6580  | Next

The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2
Allen, J. D., Ivory, D., Song, G. S., Yong, P., He, T., Andrabi, R., Burton, D., Crispin, M.
10.1101/2022.08.24.505118 — Posted: 2022-08-25
Intentions to get vaccinated against Monkeypox in Healthcare workers in France and Belgium correlates with attitudes toward COVID-19 vaccination
Gagneux-Brunon, A., Dauby, N., LAUNAY, O., Botelho-Nevers, E.
10.1101/2022.08.25.22279205 — Posted: 2022-08-25
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
Yang, L., Van Beek, M., Wang, Z., Muecksch, F., Canis, M., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., Chakraborty, A. K.
10.1101/2022.08.24.505127 — Posted: 2022-08-25
Long Covid active case finding: a co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)
Alwan, N. A., Clutterbuck, D., Pantelic, M., Hayer, J., Fisher, L., Hishmeh, L., Heightman, M., Allsopp, G., Wootton, D., Khan, A., Hastie, C., Jackson, M., Rayner, C., Brown, D., Parrett, E., Jones, G., Smith, K., Clarke, R., Mcfarland, S., Gabbay, M., Banerjee, A.
10.1101/2022.08.24.22278954 — Posted: 2022-08-25
Phenotypic evolution of SARS-CoV-2: a statistical inference approach
Benhamou, W., Lion, S., Choquet, R., Gandon, S.
10.1101/2022.08.25.22279206 — Posted: 2022-08-25
T cell responses to SARS-CoV-2 vaccination in people with multiple sclerosis differ between disease-modifying therapies
Wolf, A.-S., Ravussin, A., König, M., Overas, M. H., Solum, G., Kjonstad, I. F., Chopra, A., Holmoy, T., Harbo, H. F., Syversen, S. W., Jorgensen, K. K., Hogestol, E., Vaage, J. T., Celius, E. G., Lund-Johansen, F., Munthe, L. A., Nygaard, G. O., Mjaaland, S.
10.1101/2022.08.25.22279202 — Posted: 2022-08-25
Nirmatrelvir/ritonavir and molnuipiravir in the treatment of mild/moderate COVID-19: results of a real-life study
Gentile, I., Scotto, R., Schiano Moriello, N., Pinchera, B., Villari, R., Trucillo, E., Ametrano, L., Fusco, L., Castaldo, G., Buonomo, A. R., Federico II COVID Team
10.1101/2022.08.23.22278585 — Posted: 2022-08-25
Correlation of patient serum IgG, IgA and IgM antigen binding with COVID-19 disease severity using multiplexed SARS-CoV-2 antigen microarray and maintained relative IgA and IgM antigen binding over time
Le Berre, M., Paulovcakova, T., De Marco Verissimo, C., Doyle, S., Dalton, J. P., Masterson, C., Ribes Martinez, E., Walsh, L., Gormley, C., Laffey, J. G., McNicholas, B., Simpkin, A. J., Kilcoyne, M.
10.1101/2022.08.22.22278930 — Posted: 2022-08-25
Variability in mRNA SARS-CoV-2 BNT162b2 vaccine immunogenicity is associated with differences in the gut microbiome and habitual dietary fibre intake
Healey, G. R., Golding, L., Schick, A., Majdoubi, A., Lavoie, P., Vallance, B.
10.1101/2022.08.24.22279143 — Posted: 2022-08-25
TRENDS IN CASES, HOSPITALISATION AND MORTALITY RELATED TO THE OMICRON BA.4/BA.5 SUB-VARIANTS IN SOUTH AFRICA
JASSAT, W., Abdool Karim, S., Ozougwu, L., Welch, R., Mudara, C., Masha, M., Rousseau, P., Wolmarans, M., Selikow, A., Govender, N., Walaza, S., von Gottberg, A., Wolter, N., Pisa, P. T., Sanne, I., Govender, S., Blumberg, L., Cohen, C., Groome, M.
10.1101/2022.08.24.22279197 — Posted: 2022-08-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).